Class A G protein-coupled receptors (GPCRs) are known to form dimers and/or oligomeric arrays in vitro and in vivo. These complexes are thought to play important roles in modulating class A GPCR function. Many studies suggest that residues located on the "outer" (lipid-facing) surface of the transmembrane (TM) receptor core are critically involved in the formation of class A receptor dimers (oligomers). However, no clear consensus has emerged regarding the identity of the TM helices or TM subsegments involved in this process. To shed light on this issue, we have used the M 3 muscarinic acetylcholine receptor (M3R), a prototypic class A GPCR, as a model system. Using a comprehensive and unbiased approach, we subjected all outward-facing residues (70 amino acids total) of the TM helical bundle (TM1-7) of the M3R to systematic alanine substitution mutagenesis. We then characterized the resulting mutant receptors in radioligand binding and functional studies and determined their ability to form dimers (oligomers) in bioluminescence resonance energy transfer saturation assays. We found that M3R/M3R interactions are not dependent on the presence of one specific structural motif but involve the outer surfaces of multiple TM subsegments (TM1-5 and -7) located within the central and endofacial portions of the TM receptor core. Moreover, we demonstrated that the outward-facing surfaces of most TM helices play critical roles in proper receptor folding and/or function. Guided by the bioluminescence resonance energy transfer data, molecular modeling studies suggested the existence of multiple dimeric/oligomeric M3R arrangements, which may exist in a dynamic equilibrium. Given the high structural homology found among all class A GPCRs, our results should be of considerable general relevance.
The superfamily of G protein-coupled receptors (GPCRs) 3 represents the largest group of cell surface receptors found in nature (1, 2) . Following activation by extracellular ligands such as neurotransmitters, hormones, or sensory stimuli, GPCRs regulate an extraordinarily large number of important physiological responses, reflecting the fact that nearly 50% of drugs in current clinical use target specific GPCRs (3) . A characteristic structural feature of all GPCRs is a transmembrane (TM) core consisting of a bundle of seven TM helices (TM1-7). The TM receptor core plays a critical role in propagating the ligandinduced conformational changes to the cytoplasmic receptor surface, enabling the receptor to interact with specific classes of heterotrimeric G proteins (2, 4) .
Accumulating evidence suggests that GPCRs are able to form dimers and/or higher order oligomeric complexes (5) (6) (7) (8) (9) (10) . Most convincingly, studies with class C GPCRs, exemplified by the ␥-aminobutyric acid, type B, and metabotropic glutamate receptors, have demonstrated that dimer formation is required for agonist-induced G protein activation, at least in this subclass of GPCRs (for recent reviews see Refs. 7, 8) . Class C GPCRs form stable dimeric interactions through well characterized structural mechanisms (7, 8) . For example, the functional GABA B R1/GABA B R2 receptor dimer is stabilized by interactions involving the C-terminal tails of the two receptor subtypes (11) . The calcium-sensing and the metabotropic glutamate receptors contain extracellular cysteine residues that link adjacent receptor monomers via disulfide bridges (7) . More recently, the structural basis underlying class B GPCR dimerization/oligomerization has also become the subject of intense investigation (12) (13) (14) .
Class A receptors represent by far the largest subfamily of GPCRs, consisting of ϳ670 members in humans (2) . Monomeric class A GPCRs are able to activate G proteins when reconstituted in a high density lipoprotein phospholipid bilayer (15, 16) , suggesting that dimer formation is not essential for class A receptor function. However, the existence of class A GPCR homodimers/oligomers is strongly supported by various lines of evidence (5, 6, 10) , including recent time-resolved FRET studies demonstrating the formation of oxytocin receptor dimers in vivo (17) . Several studies suggest that such class A receptor homodimers/oligomers are endowed with altered functional properties. For example, the formation of class A GPCR complexes may affect the efficiency of agonist-induced G protein activation (18) , the extent of receptor phosphorylation (19) , or signaling selectivity (20) . Moreover, in a recent study, Han et al. (21) provided strong evidence that the two protomers contained in a D 2 dopamine receptor dimer can "communicate" with each other through an allosteric mechanism. Specifically, agonist binding to a single protomer resulted in maximum G protein activation, whereas agonist binding to the second protomer inhibited signaling (21) .
On the basis of these studies, a proper understanding of how class A GPCRs function at the molecular level requires the identification of the structural elements governing the dimerization/oligomerization of this class of receptors. Despite numerous molecular, biochemical, and biophysical studies, the molecular mechanisms underlying class A receptor dimerization (oligomerization) are not well defined. Many studies suggest that residues located on the "outer" (lipid-facing) surface of the TM helical bundle play a key role in the formation of class A receptor dimers/oligomers (6, 22, 23) . However, depending on the specific receptor under investigation, different TM helices or TM segments have been implicated in this process (see, for example, Refs. 24 -33) . As a result, no clear consensus has emerged regarding the relative roles of the different TM helices or specific TM segments in class A GPCR dimerization.
To address this issue, we used the M3R as a model system to study, in a highly systematic and unbiased fashion, which residues located on the outward-facing surface of the TM receptor core contribute to M3R dimerization/oligomerization. The M3R, a prototypic class A GPCR that preferentially couples to G proteins of the G q family, is involved in numerous important physiological functions (34 -36) . For example, recent studies with M3R mutant mice have shown that M3Rs expressed by pancreatic ␤ cells play a key role in maintaining normal blood glucose levels (37) and that neuronal M3Rs are required for proper somatic growth (38) and bone formation (39) . Moreover, Raufman et al. (40) recently demonstrated that enhanced M3R activity may play a role in the pathogenesis of colon cancer. Thus, understanding how the M3R functions at the molecular level is of considerable relevance for designing novel classes of drugs that can modulate M3R function for therapeutic purposes.
The ability of the M3R to form dimeric (oligomeric) complexes has been demonstrated by the use of various experimental techniques, including the use of functional complementation assays involving the co-expression of functionally inactive mutant M3Rs (41) , co-immunoprecipitation studies (42) , and bioluminescence resonance energy transfer (BRET) experiments (43) . To monitor receptor dimerization, we used BRET technology, which is widely used to study GPCR interactions in live cells because of its high sensitivity (44) . Specifically, we subjected all outward-facing residues (70 amino acids total) of the TM core (TM1-7) of the M3R, except for two highly conserved proline residues, to systematic alanine substitution mutagenesis. We then used BRET saturation experiments to determine the ability of the resulting mutant receptors to form receptor dimers/oligomers. This approach allowed us to assess the relative role of each TM helix and distinct TM subsections in this process. We also examined to which extent the introduced mutations affected the ligand binding and functional properties of the M3R.
Our findings strongly suggest that multiple TM subsegments located on different TM helices (TM1, -2, -4, -5, and -7) contribute to the formation of M3R dimers (oligomers). Interestingly, these structurally critical TM regions are all located within the central and endofacial portion (the part of the TM helical bundle that faces the cytoplasm) of the TM receptor core. Furthermore, our data indicate that the outward-facing surfaces of most TM helices play critical roles in proper receptor folding and/or function. Molecular modeling studies suggested the existence of multiple dimeric/oligomeric M3R arrangements, rather than a single structurally distinct dimer/ oligomer structure. Because all class A GPCRs are predicted to share a similar structure, our findings should be of broad general interest.
EXPERIMENTAL PROCEDURES

Construction of Plasmids and Mutant
Receptors-A plasmid coding for the human M3R containing a string of three hemagglutinin (HA) epitope tags at its N terminus (vector pcDNA 3.1) was obtained from the Missouri S&T cDNA Resource Center. A pOTB7 vector containing the smoothened receptor coding region (human) was purchased from the American Type Culture Collection. The pcDNA 3.1 vectors containing a FLAG epitope sequence along with either the Renilla Luciferase 8 (RLuc8 or simply Luc) or mVenus (Venus) coding regions were kindly provided by the laboratory of Dr. Jonathan Javitch (Columbia University). To fuse the FLAG epitope sequence to the N terminus and the RLuc8 and mVenus sequences to the C terminus of the M3R, the coding region of the M3R was amplified via PCR and then subcloned into the RLuc8 and mVenus vectors, respectively, using the BamHI and SacII restriction sites present in the polylinker regions of these plasmids. The two resulting constructs are referred to as M3-Luc and M3-Venus throughout. In both fusion proteins, the C terminus of the M3R was linked to the RLuc8 or mVenus sequences via a 7-amino acid linker (AAGPVAT). The M3-Luc-TM1A to -TM7A mutant receptors (for sequence information, see Table 2 ) were generated by using standard PCR-based mutagenesis techniques. The M3-Luc-derived TM subsection mutant receptors were obtained by the use of the QuikChange mutagenesis kit (Stratagene) or by employing PCR-based methods (for sequence information, see Fig. 4 ). M3-Luc receptors containing two mutated subsections were generated via standard subcloning procedures. Single point mutations were introduced into the M3-Luc construct by using the QuikChange mutagenesis kit (Stratagene). For control purposes, we also generated a construct coding for the human smoothened receptor (Smo) that contained a FLAG tag at its N terminus and that was fused to the RLuc8 construct at its C terminus. This construct (SmoLuc) was generated in a fashion analogous to that described above for the M3-Luc plasmid (vector pcDNA3.1).
Mammalian Cell Culture and Transfections-COS-7 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin, and 100 g/ml streptomycin at 37°C in a humidified 5% CO 2 incubator. All transfections were performed using Lipofectamine and PLUS reagent (Invitrogen), according to the manufacturer's instructions.
BRET Assays-COS-7 cells were seeded into 12-well tissue culture dishes (Corning Glass) at a density of ϳ50,000 cells/ well. About 24 h later, cells were co-transfected with a constant amount of plasmid DNA coding for M3-Luc or an M3-Lucbased mutant receptor (M3-Luc, 10 ng; M3-Luc-based mutant receptors, 10 -400 ng) and increasing amounts of M3-Venus DNA (2.5-140 ng). To be able to properly interpret the BRET data, we adjusted (increased) the amount of transfected plasmid DNA coding for the different M3-Luc-based mutant receptors (as compared with M3-Luc DNA) to achieve M3-Luc-like total luminescence readings. In each experiment, vector DNA (pcDNA 3.1) was added to keep the total amount of transfected DNA constant (500 or 550 ng DNA/well). After ϳ48 h, cells were trypsinized, transferred to microcentrifuge tubes, and centrifuged at 110 ϫ g for 5 min at room temperature. Cell pellets were resuspended in 500 l of PBS supplemented with glucose (1 mg/ml), ascorbic acid (1 mM), and EDTA-free complete protease inhibitor (Roche Applied Science). Subsequently, 90-l aliquots (ϳ100,000 cells) were added to individual wells of a white opaque 96-well plate (PerkinElmer Life Sciences). Total fluorescence was first measured via excitation at 485 nm and monitoring emission at 535 nm. Coelenterazine-h (Promega) was then added to each well at a final concentration of 5 M, and emissions were measured at 530 and 480 nm. Total luminescence was subsequently measured in the absence of filters. All measurements were performed using the Mithras LB 940 plate reader (Berthold Technologies). The BRET ratio was defined as the ratio of emission at 530 nm to emission at 480 nm after the addition of coelenterazine-h. The NetBRET ratio was calculated as BRET ratio Ϫ BRET ratio of cells transfected with the corresponding M3-Luc construct alone. BRET 50 values were determined as the ratio of acceptor to donor concentration that generated a half-maximal Net-BRET value. Data were analyzed using GraphPad Prism 4.0 software.
Determination of Cell Surface Receptor Expression via ELISA-COS-7 cells were seeded into 6-well tissue culture dishes (Corning Glass) at a density of ϳ120,000 cells/well. About 24 h later, cells were transfected with the various mutant receptor constructs (25-125 ng) . For each receptor construct, the amount of transfected plasmid DNA (nanogram of DNA per number of cells) was similar to that used in the BRET saturation experiments. Vector DNA (pcDNA 3.1) was added to keep the total amount of transfected DNA constant at 1,250 ng of DNA/well. The following day, cells were transferred into clear 96-well plates (Corning Glass; ϳ30,000 cells/well). About 48 h after transfection, cells were fixed with 4% formaldehyde in PBS for 30 min at room temperature, washed, and then either permeabilized via incubation with PBS containing 0.2% Triton X-100 (20 min at room temperature) or kept intact (incubation with PBS only). After blocking for 1 h in 5% bovine serum albumin (BSA, in PBS), cells were incubated for 2 h at 37°C with a polyclonal antibody directed against the FLAG epitope tag (Sigma F7425; 1:5,000 dilution in 5% BSA/PBS). Cells were then washed and incubated with a 1:5,000 dilution (in 5% BSA/PBS) of a horseradish peroxidase-conjugated anti-rabbit IgG antibody (Cell Signaling) for 1 h at 37°C. Colorimetric assays were carried out as described previously (45 Calcium Mobilization Assays-COS-7 cells were transiently transfected with receptor or pcDNA 3.1 vector DNA in 6-well tissue culture dishes (0.8 g of DNA/well). About 24 h later, cells were transferred to black, clear bottom 96-well plates (Corning Glass) at a density of ϳ30,000 cells/well. The following day, cells were tested for their ability to mediate carbacholdependent increases in intracellular calcium levels, essentially as described previously (47) . In brief, cells were incubated with 30 l/well of loading dye (FLIPR Calcium 4 assay kit; Molecular Devices) supplemented with 2.5 mM probenecid for 1 h at 37°C. Increasing concentrations of carbachol (0.1 nM to 0.1 mM) were added, and changes in cell fluorescence were measured via FLIPR (FLIPR TETRA, Molecular Devices; excitation wavelength, 470 -490 nm; emission wavelength, 515-575 nm). Increases in intracellular calcium levels were measured as peak fluorescence activity minus basal fluorescence activity. For control purposes, either WT M3R-or M3-Luc-expressing cells were included in each individual experiment. Data were analyzed by using GraphPad Prism 4.0 software.
Receptor-mediated Stimulation of Phosphatidylinositol Hydrolysis-COS-7 cells were transiently transfected with receptor or pcDNA 3.1 vector DNA in 10-cm dishes (4 g of DNA/dish). About 24 h later, cells were transferred into 6-well plates (ϳ750,000 cells/well), and 3 Ci/ml of myo- [ 3 H]inositol (20 Ci/mmol, American Radiolabeled Chemicals Inc.) was added to the growth medium. The following day, carbacholstimulated increases in inositol monophosphate (IP) production were determined by anion exchange chromatography, as described previously (45) . Data were analyzed by using GraphPad Prism 4.0 software.
Construction of Human M3R Homology Model-A human M3R homology model was constructed according to our previously published model of the rat M3R that was based on the high resolution structure of the ␤ 1 -adrenergic receptor (48, 49) , using the Prime module of the Schrödinger package (50). Notably, the rat and human M3R proteins show 98% sequence iden-tity in the modeled regions (amino acids in the human M3R: 66 -206, 221-262, and 485-561).
Generation of M3R Dimer Models-Dimeric M3R arrangements were generated by means of systematic rotations of 5°i ncrements of one M3R monomer around its axis and around the other M3R monomer. This procedure led to 5,184 dimeric structures. In each of these structures, the two M3R monomers were arranged at a distance that ensured minimum van der Waals energy, calculated according to the OPLS2005 force field. The whole operation was performed through a Python program (implemented by us ad hoc) operating within the MAESTRO environment of the Schrödinger package (51).
Filtering of M3R Dimeric Structures, Energy Minimizations, and Calculation of Protein-Protein Contacts-For each TM subsection predicted to promote M3R/M3R interactions based on the BRET data, we calculated the centroid of the C␣ atoms. For each TM subsection, we then identified the C␣ atom closest to the centroid (TM1A3, Ile-84; TM2A2, Ile-120; TM4A1, Arg-184; TM5A3, Ile-249; TM5A4, Arg-253; TM5A5, Glu-259; TM7A2, Leu-523; TM7A3, Ala-545). We next calculated the inter-monomer distances between these C␣ atoms in all 5,184 dimeric solutions (see previous paragraph). Finally, we discarded those dimeric arrangements in which none of these distances was Ͻ15 Å, leaving a total of 1,161 accepted solutions. These accepted solutions were then subjected to an energy minimization with the MacroModel computational engine, as implemented in the Schrödinger package, using octanol as the implicit solvent, with a convergence criterion set to a gradient Ͻ0.1 kJ/(Å⅐mol) (51). Two residues were defined to be in contact when the distance between any of their atoms was Ͻ2.5 Å.
RESULTS
M3-Luc and M3-Venus Show Ligand Binding and Functional
Properties Similar to the WT M3R-To generate the M3-Luc construct, a FLAG tag was fused to the N terminus, and the RLuc8 coding sequence was fused to the C terminus of the human M3R. The M3-Venus construct was obtained in a similar fashion, except that the C-terminal RLuc8 portion was replaced with the coding sequence of mVenus, a modified version of yellow fluorescent protein. Radioligand binding studies carried out with membranes prepared from transiently transfected COS-7 cells showed that both the M3-Luc and M3-Venus constructs displayed Table 1 ). In addition, functional studies showed that both fusion proteins were able to mediate carbachol-induced increases in intracellular calcium levels with carbachol EC 50 and E max values comparable with those observed with the WT M3R ( Fig. 1B and Table 1 ). These findings clearly indicate that the M3-Luc and M3-Venus constructs were properly folded and fully functional.
M3-Luc and M3-Venus Form Dimeric-Oligomeric Complexes-
To examine whether M3-Luc was able to dimerize/oligomerize with M3-Venus, we performed BRET saturation experiments using co-transfected COS-7 cells (for details see "Experimental Procedures"). In these experiments, the amount of transfected M3-Luc (BRET donor) DNA was held constant, but the amount of co-transfected M3-Venus (acceptor) DNA was gradually increased. To lower M3-Luc B max values to muscarinic receptor levels observed in native tissues (52) , the amount of transfected M3-Luc plasmid DNA was reduced to 10 ng per well (12-well plate), resulting in a B max value of ϳ300 fmol/mg protein, as determined in [ 3 H]NMS saturation binding studies. The resulting data could best be fitted by a classical saturation isotherm in which NetBRET signals increased as a hyperbolic function of the concentration of the acceptor (r ϳ0.95; Fig. 2 ), indicative of a specific interaction between M3-Luc and M3-Venus, as opposed to random collisions between these two proteins in the membrane (43, 44, (53) (54) (55) (56) .
For control purposes, we carried out analogous studies with COS-7 cells co-transfected with a different BRET donor, SmoLuc, and M3-Venus (note that Smo-Luc contained the RLuc8 sequence fused to the C terminus of the human smoothened receptor). In this case, the observed NetBRET ratios were substantially smaller than those observed in the M3-Luc/M3-Venus co-expression experiments and could best be fitted by a straight line (r ϭ 0.97; Fig. 2 ), indicative of nonspecific interactions between the two fusion proteins (43, 44, 53, 56). from three independent experiments, each performed in duplicate. B, calcium mobilization assays were carried out using intact COS-7 cells expressing the indicated receptors. Carbachol-induced increases in intracellular calcium levels were determined as maximum fluorescence Ϫ basal fluorescence (before the addition of carbachol). Cells expressing the WT M3R (red) were included as a control in each individual experiment. Data were normalized relative to the carbachol E max value obtained with the WT M3R (ϭ 100%). Data are given as means Ϯ S.E. from three independent experiments.
To monitor M3-Luc and M3-Venus expression, we assessed total luminescence by the BRET donor, M3-Luc, and total fluorescence of the acceptor, M3-Venus, respectively (for details, see "Experimental Procedures"). In parallel, we carried out Previous BRET saturation experiments (43), as well as biochemical studies (42) , demonstrated that M3R dimerization/ oligomerization is not affected by the presence of muscarinic agonists. For this reason, all BRET studies described below were carried out in the absence of muscarinic ligands. Also, for the sake of simplicity, we often simply use the term "receptor dimerization" to refer to the formation of dimeric and/or oligomeric receptor complexes.
Studies with Mutant M3Rs in Which All Outward-facing Residues of the Individual TM Helices Were Replaced with Alanine-
The goal of this study was to identify TM regions or specific amino acids contained within these regions that are involved in M3R dimerization. Specifically, we focused on the TM residues facing the lipid bilayer, based on the outcome of previous studies impli- 
H͔NMS binding and functional properties of mutant M3Rs used in this study
The indicated receptors were transiently expressed in COS-7 cells. Equal amounts of plasmid DNA were used for transfections (radioligand binding studies, 4 g of DNA/10-cm dish; functional assays, 0.8 g of DNA/well (6-well dish)). The composition of the individual mutant M3Rs is shown in Table 2 and Fig. 4 cating such residues in GPCR dimerization (6, 22, 23) . We recently generated a three-dimensional model of the TM core of the M3R (48), aided by the high resolution crystal structure of the turkey ␤ 1 -adrenergic receptor (49), a biogenic amine receptor that shares a high degree of structural homology with the M3R. The M3R model enabled us to predict which amino acids are located on the outer surface of the TM helical bundle (TM1-7; Table 2 ; supplemental Fig. 2) . To study the role of these residues in M3R dimerization, we subjected all of these amino acids (70 residues total), except for two highly conserved prolines (see below for details), to systematic alanine substitution mutagenesis, using the M3-Luc construct as a template.
Initially, we generated seven mutant M3-Luc-based mutant receptors in which all "outward-facing" residues of the individual TM helices, except for Pro-202 4.59 and Pro-506 6.50 , were replaced with alanine (M3-Luc-TM1A, M3-Luc-TM2A, etc.). Pro-202 4.59 and Pro-506 6.50 were left intact because it is has been shown that these two proline residues are required for proper M3R folding (57) . The amino acids that were subjected to alanine mutagenesis in the seven mutant M3Rs, together with their positions according to the Ballesteros-Weinstein numbering system (58), are shown in Table 2 .
To examine whether the M3-Luc-TM1A to -TM7A mutant receptors were able to fold properly, we first carried out radioligand binding and calcium mobilization assays. We found that all mutant receptors, except for M3-Luc-TM4A, completely lost the ability to bind [ 3 H]NMS (Table 1) and to mediate carbachol-dependent increases in intracellular calcium levels (Table 1 and Fig. 3A) , indicative of severe deficits in receptor folding. These six M3-Luc-based mutant receptors (M3-Luc-TM1A to -TM3A and M3-Luc-TM5A to -TM7A) also failed to yield saturable BRET curves following co-expression with M3-Venus (Fig. 3B) . Given their lack of ligand binding and functional activity, the deficits displayed by these mutant M3Rs in the BRET assays are most likely caused by receptor misfolding, rather than due to the disruption of specific structural motifs critical for M3R dimerization (oligomerization).
However, the M3-Luc-TM4A construct, which contained nine alanine substitutions on the "outer" surface of TM4 (Table  2) , retained the ability to bind [ 3 H]NMS with high affinity (note, however, that receptor density (B max ) was reduced by ϳ75%; Table 1 ). Moreover, this receptor was able to efficiently couple to G proteins in an agonist-dependent fashion, as shown in calcium mobilization assays (Fig. 3A and Table 1 ). To test the We generated seven M3-Luc-based mutant receptors (M3-Luc-TM1A to -TM7A) in which all outward-facing residues of each individual TM helix (TM1-7) were simultaneously replaced with alanines (see text for details). The Ballesteros/Weinstein number (BW#) is also provided for each targeted residue. hypothesis that the outer surface of TM4 plays a role in M3R dimerization, we carried out BRET saturation assays using COS-7 cells co-expressing the M3-Luc-TM4A construct with M3-Venus. To be able to properly interpret the BRET data, we increased the amount of transfected M3-Luc-TM4A DNA (as compared with the amount of transfected M3-Luc DNA) to achieve similar total luminescence readings (M3-Luc-TM4A versus M3-Luc) (see "Experimental Procedures" for details). Under these experimental conditions, the M3-Luc-TM4A receptor showed a similar degree of cell surface expression as the M3-Luc construct, as determined via ELISA (Table 3) . The M3-Luc-TM4A receptor yielded saturable BRET curves (the NetBRET ratios yielded a hyperbolic curve; Fig. 3B ), suggesting that this mutant receptor retained the ability to interact with M3-Venus. However, this interaction was characterized by a 5.7 (Ϯ 0.1)-fold increase (n ϭ 3) in BRET 50 (ratio of energy acceptor/energy donor that generates a half-maximal NetBRET signal; Fig. 3B ), as compared with cells co-expressing M3-Luc and M3-Venus, supporting the concept that the outward-facing residues of TM4 play a role in M3R dimerization. As discussed elsewhere, BRET 50 values are considered useful measures of the relative affinities between specific BRET donor and acceptor fusion proteins (44, (53) (54) (55) (56) 59 ). COS-7 cells co-expressing M3-Luc-TM4A and M3-Venus also showed a significant reduction in the maximal BRET signal (BRET max ), as compared with cells co-expressing M3-Luc and M3-Venus (Fig. 3A) . However, changes in BRET max are difficult to interpret because they may be caused by various factors, including altered dimer numbers (concentrations) and/or changes in the distance between or orientation of BRET donor and acceptor pairs within the dimer (44, 53, 56) .
Studies with Mutant M3Rs in Which Specific Subsets of Outward-facing Residues of the Individual TM Helices Were
Replaced with Alanine-As outlined above, the M3-Luc-TM1A, -TM2A, -TM3A, -TM5A, -TM6A, and -TM7A mutant receptors were unable to bind [ 3 H]NMS and to couple to G proteins (Table 1 and Fig. 3A) , suggesting that the various alanine substitutions interfered with proper M3R folding. In an attempt to generate properly folded mutant M3Rs that would yield meaningful results in the BRET assays, we created a new set of M3-Luc-based mutant receptors that contained a smaller Table 2 (also see Fig. 4 ): M3-Luc-TM1A (green), -TM2A (dark blue), -TM3A (orange), -TM4A (purple), -TM5A (light blue), -TM6A (pink), and -TM7A (gray). The curves generated with the nonmutated M3-Luc construct are shown in red. A, calcium mobilization assays were carried out using intact COS-7 cells expressing the indicated receptor constructs in the presence of increasing concentrations of carbachol. Increases in intracellular calcium levels were expressed as peak fluorescence Ϫ basal fluorescence before the addition of carbachol. Data were normalized relative to the carbachol E max value obtained with M3-Luc (ϭ 100%), which was included as a control in each individual experiment. Data are given as means Ϯ S.E. from a representative experiment, performed in duplicate. Two additional experiments gave similar results. B, BRET saturation studies were performed using intact COS-7 cells expressing a constant amount of the different M3-Luc receptors together with increasing amounts of M3-Venus. Data were obtained and analyzed as described in the legend to Fig. 2 . The panel shows data representative of two or three independent experiments, each performed in duplicate. number of alanine substitutions. Specifically, we subdivided the outward-facing residues of each individual TM helix into two to five subgroups (based on the three-dimensional model of the TM core of the M3R), followed by alanine substitution mutagenesis. Using this approach, we generated 23 additional M3-Luc-based mutant receptors (Fig. 4) . In the following, we refer to the resulting mutant M3Rs simply as TM subsection mutants. We named these mutant M3Rs according to the targeted TM helix and the order of the targeted subsection in the receptor coding sequence (M3-Luc-TM#A#; Fig. 4) . Luc-TM1A3, -TM2A2, -TM4A1, -TM5A3, TM5A4, -TM7A2, and  -TM7A3; Table 1 ), raising the possibility that NMS might stabilize an inactive conformation of these receptors (NMS is known to behave like an inverse muscarinic agonist). The inactive states of GPCRs are usually characterized by low agonist binding affinities. However, we found that none of these mutant receptors showed reduced binding affinities for the muscarinic agonist, carbachol (carbachol In this scheme, all amino acids located within the TM core (TM1-7) of the human M3R are shown. The amino acids predicted to project away from the TM helical bundle are highlighted in bold. Using the M3-Luc receptor as a template, the residues grouped by brackets were simultaneously replaced with alanines, yielding a total of 23 TM subsection mutants (see text for details). The most highly conserved residue in each TM helix is indicated by the corresponding Ballesteros/Weinstein number (superscript; Ref. 58) . Note that Pro-202 4.59 and Pro-506 6.50 were left intact, because these two proline residues are known to be required for proper M3R folding (57) . Moreover, the three endogenous alanine residues that are located on the outer surface of the TM receptor core (Ala-238, Ala-495, and Ala-545) were not mutated to any other residue.
Ligand Binding and G Protein-coupling Properties of TM Subsection Mutant M3Rs-All
22.7; M3-Luc-TM7A3, 56.3 Ϯ 31.1; n ϭ 2-4), strongly suggesting that the introduced mutations do not stabilize an inactive conformation of the receptor.
BRET Analysis of TM Subsection Mutant M3Rs-To examine whether the 23 TM subsection mutants were impaired in their ability to form receptor dimers, we performed BRET saturation assays using COS-7 cells co-expressing the individual mutant M3R constructs with M3-Venus. To be able to properly interpret the BRET data, we adjusted the amounts of transfected mutant receptor DNAs to achieve M3-Luc-like total luminescence readings (see "Experimental Procedures" for details). Under these experimental conditions, all mutant receptors, except for M3-Luc-TM3A2 which showed greatly reduced cell surface expression, showed a similar degree of cell surface expression as M3-Luc (Table 3) .
BRET saturation assays revealed that 12 of the 23 TM subsection mutants yielded BRET 50 values that were not significantly different from the corresponding value observed with M3-Luc (Fig. 5) . However, eight TM subsection mutant M3Rs displayed significantly increased (ϳ4 -8-fold) BRET 50 values (M3-Luc-TM1A3, -TM2A2, -TM4A1, TM5A3, -TM5A4, -TM5A5, -TM7A2 and -TM7A3). With the exception of M3-Luc-TM2A2, TM5A4, and TM7A2, which showed significantly reduced carbachol potencies (ϳ10 -40-fold), these mutant receptors showed functional properties similar to M3-Luc (Table 1) . The M3-Luc-TM5A4 receptor displayed the largest decrease in carbachol potency (ϳ40-fold; Table 1 ), consistent with the outcome of a previous mutagenesis study indicating that the Y255 5.62 A point mutation contained in this mutant construct severely interferes with M3R/G q coupling (60) .
Three of the 23 TM subsection mutants (TM3A2, -TM6A1, and -TM6A3) failed to yield saturable BRET curves following co-expression with M3-Venus (Fig. 6) . The same receptors were also deficient in binding the muscarinic radioligand Table 1 ), suggesting that the structural integrity of these three TM subregions is critical for proper receptor folding.
The M3-Luc-TM1A3, -TM5A4, and -TM7A2 mutant receptors showed the largest shifts in BRET 50 values (6 -8-fold). In an attempt to disrupt M3R dimerization more extensively, we generated the following three combination mutant receptors: M3-Luc-TM1A3/TM5A4, -TM1A3/TM7A2, and -TM5A4/ TM7A2. However, these three mutant M3Rs were unable to bind [ Studies with Mutant M3Rs Containing Single Alanine Substitutions-As described above, the M3-Luc-TM1A3, -TM5A4, and -TM7A2 mutant receptors showed the most pronounced increases in BRET 50 values (Fig. 5) . In an attempt to identify single amino acids involved in M3R dimerization, we generated 10 additional mutant M3Rs (in the M3-Luc background) in which all amino acids contained within the TM1A3, -TM5A4, and -TM7A2 subsegments were replaced, one at a time, with alanine (supplemental Table 1 ).
All resulting mutant receptors were able to bind [ 3 H]NMS with high affinity and, with the exception of the Y255A con- Table 2 . NetBRET ratios were determined as described in detail under "Experimental Procedures." The depicted data are from a representative experiment performed in duplicate. At least two additional experiments gave similar results. struct, showed functional properties similar to the M3-Luc receptor from which they were derived (supplemental Table 1 ). The Y255A receptor showed a pronounced reduction in receptor expression levels (B max ) and carbachol potency and efficacy (supplemental Table 1 ).
All 10 M3-Luc-based mutant receptors containing single alanine substitutions produced saturable BRET curves when expressed with increasing amounts of M3-Venus (data not shown). Nine of the 10 newly generated mutant receptors did not yield any significant shifts in BRET 50 values, as compared with M3-Luc (Fig. 7) . Interestingly, the M3-Luc-Y255A receptor displayed an ϳ3-fold increase in BRET 50 , as compared with M3-Luc (Fig. 7) , suggesting that Tyr-255 may contribute to the formation of M3R dimers. It should be noted that the amounts of transfected DNAs were adjusted in the BRET assays, so that the M3-Luc-Y255A and M3-Luc constructs were expressed at similar levels. (Figs. 5 and 8A ) similar to M3-Luc. However, in calcium mobilization assays, this mutant receptor showed a ϳ50% reduction in carbachol E max , as compared with M3-Luc (Table 1) . To confirm the results obtained in the calcium assay, we also measured receptor-mediated IP accumulation. In this assay, the M3-Luc-TM7A1 mutant receptor showed a similar degree of functional impairment (carbachol E max ϭ 42.6 Ϯ 2.7% of M3-Luc; Fig. 8B ). The M3-Luc-TM7A1 construct contains two point mutations within the outward-facing segment of the extracellular end of TM7, T524 7.33 A, and F525 7.34 A (Figs. 4 and 8D) . We therefore generated two additional M3-Luc-based mutant receptors containing either the T524 7.33 A or the F525 7.34 A point mutation (M3-Luc-T524A and M3-Luc-F525A, respectively). The two resulting mutant receptors showed [ . In IP assays, both mutant receptors showed a moderate reduction (by ϳ20%) in carbachol E max values (Table 4 and Fig. 8B) .
[ 3 H]NMS/carbachol inhibition binding studies demonstrated that the M3-Luc-TM7A1, M3-Luc-T524A, and M3-Luc-F525A constructs were able to bind carbachol with similar affinity as M3-Luc (Fig. 8C and Table 4 ), suggesting that Thr-524 7.33 and Phe-525 7.34 are required for efficient M3R activation.
Molecular Modeling Studies-We next used a molecular modeling approach to formulate hypotheses on possible M3R dimeric arrangements that were compatible with the BRET data described above. Specifically, we generated in silico 5,184 dimeric combinations of the human M3R through a series of systematic 5°rotations of one M3R monomer around its axis and around the other M3R monomer. We implemented this approach through a Python script that we wrote to operate within the Schrödinger modeling package (51). This systematic approach to receptor-receptor docking allows the generation of all possible orientations of receptor dimers. The solutions obtained by using this strategy can then be filtered to accept only those structures that are compatible with the experimental data. In this study, we filtered the 5,184 solutions by accepting only those dimeric arrangements in which at least two TM subregions predicted to promote M3R/M3R interactions (based on the BRET saturation data) were located adjacent to each other at the dimer interface (distance between C␣ atoms Ͻ15 Å; see "Experimental Procedures" for details). Among the 1,165 solutions that we obtained after this filtering process, no single dimeric structure was observed in which all TM subregions predicted to be involved in M3R dimer formation were located at the dimer interface. However, the BRET data that we obtained were consistent with the existence of four distinct low energy dimeric arrangements (Fig. 9) . These four structures were characterized by the following TM interfaces: TM5-TM5 (Fig. 9A) , TM6-TM7 (Fig. 9B) , TM4-TM5 (Fig. 9C) , and TM1-TM2 (Fig. 9D) . In the order of increasing energy, these dimeric arrangements were ranked 1st, 3rd, 29th, 39th, respectively, among the 1,165 solutions that were obtained after the filtering process. In the four dimeric arrangements shown in Fig. 9 , almost all TM subregions predicted to participate in M3R/M3R interactions were located at specific dimer interfaces, except for TM2A2 and TM5A3 (also see supplemental Table 2 ).
Interestingly, the lowest energy model (Fig. 9A) predicts that Tyr-255 of one M3R monomer makes key contacts with several residues (Arg-253, Lys-256, and Lys-260) of the adjacent monomer (supplemental Fig. 3) , consistent with the BRET data shown in Fig. 7 . According to this model, Tyr-255 may also facilitate the interaction of Glu-259 on the same monomer with Lys-260 of the adjacent monomer.
We also wanted to examine whether our BRET data were compatible with previously proposed models of class A GPCR dimers and/or oligomers. Specifically, we reconstructed an M3R hexamer (supplemental Fig. 4) , reflecting the arrangement proposed for rhodopsin on the basis of molecular modeling and atomic force microscopy studies (25, 61) . In this hexa- meric M3R complex, several, but not all, TM subsections predicted to promote M3R/M3R interactions based on the BRET data (TM4A1, TM5A4, and TM5A5) are located at the interface connecting monomers into dimers (A and B and D and E in supplemental Fig. 4) or at the interface linking dimers into rows (A-D, B-E, and C-F in supplemental Fig. 4 ) (for predicted intermonomeric contact sites, also see supplemental Table 3 ). Notably, the interface between the A-D, B-E, and C-F monomers (supplemental Fig. 4 ) is similar to the M3R dimer interface depicted in Fig. 9C . However, the interface connecting rows of dimers into arrays of rows (B and C and D-F in supplemental Fig. 4) did not involve any of the structurally critical TM subsegments identified in the BRET studies.
Finally, our BRET data were also compatible with a model involving a TM4-TM4 interface, without the participation of TM5, as proposed for the activated state of the D 2 dopamine receptor (27) . The lowest energy M3R dimer model characterized by a TM4A1-TM4A1 interface, ranked 474th in terms of increasing energy, is shown in supplemental Fig. 5 (also see supplemental Table 4 ). The relatively low ranking of this dimeric arrangement may be due to the fact that our model of the M3R monomer is based on a template crystallized in its inactive state (49) .
DISCUSSION
The molecular mechanisms underlying the formation of class A GPCR dimers/oligomers are not well understood at present. In this study, we used BRET technology to examine the 7.34 and Thr-524 7.33 (red). These residues are located in close proximity to Lys-523 7.32 (gray) which, according to our M3R model, forms a cation/aromatic interaction with Phe-222 (yellow) in the second extracellular loop (EL2). In the ␤ 2 -adrenergic receptor, the residues corresponding to Lys-523 and Phe-222 in the M3R are Lys-305 7.32 and Asp-192, which are predicted to form a salt bridge (71) . NMR spectroscopic data suggest that agonist activation of the ␤ 2 -adrenergic receptor involves a reorientation of the Lys-305/Asp-192 salt bridge (71) . ELL3, third extracellular loop.
TABLE 4 Carbachol binding and functional properties of mutant M3Rs containing alanine substitutions within the extracellular end of TM7
The indicated M3-Luc-based receptors were transiently expressed in COS-7 cells. Equal amounts of DNA were used for transfections (IP accumulation assays, 0.8 g of DNA/well (12-well dish); carbachol binding studies, 4 g of DNA/10-cm dish). IP accumulation assays and carbachol binding studies were performed as described in detail under "Experimental Procedures." Data are given as means Ϯ S.E. of two or three independent experiments, all performed in duplicate. contribution of the outward-facing residues of the TM core of a class A GPCR (M3R) to receptor dimerization (oligomerization) in a comprehensive, unbiased fashion. Because of its high sensitivity, BRET technology is widely used to study receptor/ receptor interactions in live cells (44) . In general, classical BRET experiments do not allow conclusions regarding the subcellular localization of the GPCR dimers/oligomers under investigation. However, a convincing body of evidence indicates that such GPCR complexes are already assembled in the endoplasmic reticulum and then trafficked to the cell surface (for a recent review, see Ref. 62) . Thus, the BRET approach used in this study examined the formation of all cellular M3R dimers/oligomers. One of the key findings that emerged from this study is that no single TM domain or TM subregion plays a dominant role in M3R dimer formation. However, BRET saturation studies strongly suggested that multiple TM segments are involved in M3R/M3R interactions. Specifically, we identified the following eight TM subsection mutant M3Rs (template, M3-Luc) that displayed significant increases in BRET 50 values when co-expressed with M3-Venus (Fig. 5 ): M3-Luc-TM1A3, -TM2A2, -TM4A1, -TM5A3, -TM5A4, -TM5A5, -TM7A2, and -TM7A3 (see Fig. 4 for mutant receptor structures). BRET assays were carried out using conditions under which all M3-Luc-based mutant receptors showed similar total and similar cell surface expression levels as M3-Luc. Moreover, all eight mutant M3Rs were able to bind [
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3 H]NMS with high affinity, similar to the WT M3R. On the basis of these observations, it is unlikely that the increases in BRET 50 values displayed by the M3-Luc-TM1A3, -TM2A2, -TM4A1, -TM5A3, -TM5A4, -TM5A5, -TM7A2, and -TM7A3 mutant receptors are caused by improper receptor folding or trafficking. Our data rather support the concept that the TM segments targeted in these eight mutant M3Rs contribute to the formation of dimeric or oligomeric M3R complexes. Interestingly, all eight TM subsection mutant M3Rs that showed significantly increased BRET 50 values contained alanine substitutions near the middle or the cytoplasmic ends of different TM helices, suggesting that the endofacial portion of the TM receptor core plays a critical role in M3R dimerization/oligomerization.
The M3-Luc-TM1A3, -TM5A4, and -TM7A2 mutant receptors showed the largest shifts in BRET 50 values (6 -8-fold). In an attempt to identify single amino acids involved in M3R dimerization, we introduced single alanine substitutions into the TM1A3, -TM5A4, and -TM7A2 TM subsegments. In BRET assays, 9 of 10 newly generated mutant receptors did not yield any significant shifts in BRET 50 values, as compared with M3-Luc (Fig. 7) . This finding may reflect the fact that the M3R/ M3R interface involves a large number of interactions and that mutation of a single residue located at this interface may not have a significant impact on the overall strength of M3R/M3R interactions.
Interestingly, the M3-Luc-Y255A receptor displayed an ϳ3-fold increase in BRET 50 , as compared with M3-Luc (Fig. 7) , suggesting that Tyr-255 may contribute to the formation of M3R dimers, consistent with molecular modeling studies (supplemental Fig. 3 ). However, because the Y255A mutant receptor also showed clear functional deficits (supplemental Table  1 ), it remains unclear to what extent the BRET data that we obtained with this mutant receptor were affected by indirect conformational changes induced by the Y255A point mutation.
For obvious reasons, the simultaneous involvement of the eight identified TM subregions, located on five different TM helices, in the formation of a simple dimer interface is not feasible. However, because the BRET approach used in this study cannot distinguish between M3R dimers and higher order oligomers, it is possible that these TM subregions participate in receptor/receptor interactions in higher order M3R complexes. Consistent with this notion, the existence of class A GPCR oligomers has been demonstrated by different experimental techniques (25, 28, 61, (63) (64) (65) (66) .
Alanine substitution mutagenesis of two TM6 subsegments (TM6A1 and TM6A3) led to mutant receptors that were deficient in [ 3 H]NMS binding and failed to yield saturable BRET curves (Fig. 6) , indicative of improper receptor folding. Because of these folding deficits, our data cannot exclude the possibility that these TM6 subsegments are also involved in the formation of M3R dimers (oligomers).
By using a molecular modeling approach, we were unable to generate a single M3R dimeric arrangement in which all or most of the TM subsections predicted to be involved in M3R/ M3R interactions (based on the BRET saturation experiments) were located at the dimer interface, as expected. Instead, molecular modeling studies suggested the existence of multiple energetically favorable M3R dimers endowed with different geometries. Specifically, the modeling studies predicted four distinct dimeric arrangements in which almost all TM subregions predicted to participate in M3R/M3R interactions based on the BRET studies were located at specific dimer interfaces, except for TM subdomains TM2A2 and TM5A3 (Fig. 9) . One possibility is that the latter two TM subsections affect M3R/ M3R interactions in an indirect fashion due their close proximity to likely dimerization interfaces (see Fig. 9 , A and C, for subsection TM5A3 and Fig. 9D for subsection TM2A2, respectively). Interestingly, the TM5A4 subsection is located at the dimer interface in three of the four low energy M3R dimeric arrangements shown in Fig. 9 . Consistent with the potential importance of this TM subsegment in M3R dimerization, we found that introduction of a single point mutation (Y255A) into this region led to a significantly impaired BRET signal (see above).
The existence of multiple dimeric M3R arrangements, which may exist in a dynamic equilibrium, is consistent with the outcome of recent studies suggesting that class A GPCR dimer/ oligomer formation may occur in a reversible, transient fashion, as shown for the M 1 muscarinic receptor (M1R; Ref. 67), the ␤ 1 -adrenergic receptor (64) , and the D 1 dopamine receptor (68) . For example, Hern et al. (67) used internal reflection fluorescence microscopy in living cells to visualize individual M1R molecules stably expressed in a CHO cell line. Using this approach, the authors demonstrated that M1Rs undergo an interconversion between monomers and dimers on the time scale of seconds. Because the M3R and the M1R show a very high degree of sequence identity, particularly within the TM helical bundle (34) , it is likely that the formation of M3R dimers is also transient in nature. One possible scenario therefore is that M3R monomers are able to form short lived dimeric complexes by using different outward-facing surfaces of the TM helical bundle, depending on the relative orientation of the two M3R monomers as they approach each other in the membrane. Such a model would be consistent with the outcome of the BRET saturation studies, suggesting that many different TM subregions located within various TM helices can participate in M3R/M3R interactions.
Our experimental data are only partially compatible with several of the dimeric and oligomeric class A GPCR arrangements proposed in the literature (25, 27, 28, 61, 65, 69, 70) . Most of these models propose the existence of oligomeric receptor complexes involving TM4, TM5, or TM1 interfaces. One of the best characterized models is that of a rhodopsin hexamer (Protein Data Bank code 1N3M) that has been established based on molecular modeling and atomic force microscopy studies (25, 61) . Our BRET data, complemented by molecular modeling studies, are, at least partially, compatible with the formation of rhodopsin-like M3R dimers and the association of such dimers into a rhodopsin-like tetramer (supplemental Fig. 4) . However, our data are not consistent with a model involving interactions between individual M3R tetramers, as proposed for rhodopsin (25, 61) .
It should be noted that the M3R dimer models that we generated are hypothetical in nature, primarily due to the lack of a high resolution x-ray structure of the M3R and to difficulties inherent in the molecular modeling of membrane-bound proteins. However, because these models were fully compatible with the experimental BRET data, they should prove useful for generating new hypotheses and guiding future experiments to probe the molecular basis of GPCR dimerization.
Several of the eight TM subsection mutant receptors that showed significant deficits in the BRET assays (e.g. M3-Luc-TM2A2, -TM5A4, or TM7A2) also displayed pronounced reductions in carbachol potencies and/or E max values in functional assays (calcium mobilization assays). It remains unclear at present whether these functional deficits are due to impaired M3R dimerization (oligomerization) or whether the introduced alanine substitutions led to impaired receptor/G protein coupling by exerting indirect allosteric effects on M3R structure. Consistent with this latter scenario, it has been shown that class A GPCR monomers can interact with heterotrimeric G proteins with high efficacy (15, 16) .
We also examined the ligand binding and G protein-coupling properties of all mutant M3Rs that we generated for this study. This analysis led to the interesting observation that six of the seven mutant receptors in which all outward-facing residues of the individual TM domains were simultaneously replaced with alanines led to a total loss of receptor activity (M3-Luc-TM1A, -TM2A, TM3A, -TM5A -TM6A, and -TM7A), indicative of M3R misfolding. This finding supports the concept that the molecular nature of the outward-facing residues of six of the seven TM helices (except for TM4) is critical for proper M3R folding.
We identified nine M3-Luc-based mutant receptors that failed to yield saturable BRET curves, indicative of nonspecific receptor/receptor interactions. In six of these receptors, all outward-facing residues of either TM1-3 and -5-7 were simultaneously replaced with alanines (Table 2) , and in three of these receptors, specific TM subregions were targeted by alanine substitution mutagenesis (TM3A2, -TM6A1, and TM6A3; Fig.  4 ). However, these nine mutant receptors showed little or no specific [ 3 H]NMS binding activity and were unable or severely impaired in their ability to couple to G proteins (Table 1) . It is therefore likely that the deficits that these mutant M3Rs displayed in the BRET saturation assays were due to receptor misfolding, rather than due to the disruption of specific structural motifs critical for M3R dimerization (oligomerization). In any case, these findings clearly highlight the importance of the outward-facing surfaces of six of the seven TM helices (except for TM4) in proper M3R assembly.
We also made the intriguing observation that the M3-Luc-TM7A1 receptor, in which two residues located near the extracellular end of TM7 were replaced with alanines (Thr-524 7.33 and Phe-525 7.34 ), behaved like the M3-Luc construct in BRET assays but was severely impaired in its ability to mediate agonist-dependent G protein activation. Radioligand binding studies showed that the M3-Luc-TM7A1 receptor was expressed at similar levels as the M3-Luc construct and that the two point mutations had no significant effect on agonist (carbachol) binding affinities. In the M3R, Thr-524 7.33 , and Phe-525 7.34 are predicted to be located in close proximity to Lys-523 7.32 which, according to our M3R model, forms a cation-aromatic interaction with Phe-222 in the second extracellular loop (EL2, Fig.  8D ). Interestingly, in the ␤ 2 -adrenergic receptor, Lys-305 7.32 and Asp-192, the residues corresponding to Lys-523 and Phe-222 in the M3R, are engaged in a salt bridge (71) . NMR spectroscopic data suggest that agonist activation of the ␤ 2 -adrenergic receptor involves a reorientation of the Lys-305/Asp-192 salt bridge and that this conformational change may be critical for proper receptor function (71) . Our findings therefore support a model in which the Thr-524 7.33 /Phe-525 7.34 amino acid pair represents a novel sequence motif whose structural integrity is critical for the ability of the M3R to adopt its functionally active conformation induced or stabilized by agonist binding.
In conclusion, in this study, we used a comprehensive, unbiased approach to identify M3R regions/amino acids located on the outer surface of the TM helical bundle that participate in the formation of M3R dimers (oligomers). We found that M3R/ M3R interactions are not dependent on the presence of one specific structural motif but involve the outer surfaces of multiple TM subsegments located on TM1, -2, -4, -5, and -7. Because the M3R is a prototypic member of the class A receptor superfamily, our findings should be of broad general relevance.
